Hey community 👋 do you already know CapsoVision Inc.a newly listed MedTech company with a focus on capsule endoscopy and AI-supported diagnostics?
The company is developing capsules that patients can swallow to examine the small intestine or, in future, the large intestine -> non-invasively.
This capsule is approved worldwide, wireless incl. 360° panorama.
IPO was completed on July 3, 2025.
Some figures:
Turnover (TTM) approx. USD 12 million
YoY growth +38 %
Gross margin 63 %
Loss (TTM) approx. USD -21 million
EV/Sales approx. 16×
Cash after IPO ~26m USD
Of course, this is not a dividend stock - high losses, high expectations, but also:
✅ Real product on the market
✅ Innovation with AI potential
✅ Good gross margin & sales growth
✅ Just went public → plenty of room for discovery
👉 I'm curious to see whether CapsoVision will become a success story à la "MedTech Hidden Champion" in 2-3 years - or whether it will remain an attempt.
What do you think?
$CV
#ipo
#medtech
#medizin
#health
#gesundheit
#aktie
#nasdaq
#medical
#gesund
#pharma
#international
#getquin
#deutschland
#österreich
#schweiz
#usa
